Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3,205 JPY | +0.47% | +0.47% | -1.99% |
25/04 | Hidehiro Imatsu named president of Goldman Sachs Japan | RE |
21/03 | Tranche Update on Mochida Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 15, 2023. | CI |
Business Summary
Number of employees: 1,529
Sales per Business
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Drug-related
94.3
%
| 104,447 | 94.8 % | 97,340 | 94.3 % | -6.80% |
Health Care
5.7
%
| 5,732 | 5.2 % | 5,920 | 5.7 % | +3.28% |
Sales per region
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Japan
100.0
%
| 110,179 | 100.0 % | 103,261 | 100.0 % | -6.28% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Naoyuki Mochida
PSD | President | 65 | 01/91/01 |
Chief Administrative Officer | 61 | 01/17/01 | |
Chief Tech/Sci/R&D Officer | 66 | 01/82/01 | |
Chu Sakata
COO | Chief Operating Officer | 64 | 01/11/01 |
Motoi Mitsuishi
BRD | Director/Board Member | - | - |
Yutaka Kawakami
BRD | Director/Board Member | 64 | 01/12/01 |
Junichi Sakaki
BRD | Director/Board Member | 63 | 01/09/01 |
Keiichi Sagisaka
BRD | Director/Board Member | 66 | 01/80/01 |
Masayoshi Takeda
IRC | Investor Relations Contact | - | - |
Junichi Makino
HRO | Human Resources Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Naoyuki Mochida
PSD | President | 65 | 01/91/01 |
Nana Otsuki
BRD | Director/Board Member | 59 | 29/21/29 |
Keiichi Sagisaka
BRD | Director/Board Member | 66 | 01/80/01 |
Chu Sakata
COO | Chief Operating Officer | 64 | 01/11/01 |
Tomoo Kugisawa
BRD | Director/Board Member | 69 | 01/12/01 |
Chief Tech/Sci/R&D Officer | 66 | 01/82/01 | |
Chief Administrative Officer | 61 | 01/17/01 | |
Yutaka Kawakami
BRD | Director/Board Member | 64 | 01/12/01 |
Megumi Kawa
BRD | Director/Board Member | - | - |
Motoi Mitsuishi
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 37,470,000 | 20,210,067 ( 53.94 %) | 2,974,069 ( 7.937 %) | 53.94 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
NISSUI CORPORATION 2.56% | 8,000,000 | 2.56% | 50,750,240 $ |
2,018,491 | 5.39% | 42,945,192 $ | |
2,200,000 | 1.70% | 12,486,694 $ | |
707,600 | 0.35% | 10,391,099 $ | |
611,000 | 0.00% | 6,285,815 $ | |
TOHO HOLDINGS CO., LTD. 0.32% | 243,400 | 0.32% | 5,873,315 $ |
SUZUKEN CO., LTD. 0.22% | 172,920 | 0.22% | 5,300,313 $ |
319,100 | 0.14% | 4,891,551 $ | |
913,000 | 0.23% | 2,400,962 $ | |
251,500 | 1.03% | 1,445,738 $ |
Company contact information
Mochida Pharmaceutical Co., Ltd.
1-1 Ichigayahonmuracho Shinjuku-ku
162-0845, Tokyo
+81 3 3358 7211
http://www.mochida.co.jpSector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.99% | 735M | |
+31.52% | 690B | |
+21.96% | 546B | |
-5.21% | 358B | |
+17.02% | 323B | |
+5.01% | 287B | |
+13.68% | 235B | |
+3.81% | 199B | |
-10.63% | 195B | |
+3.98% | 161B |
- Stock Market
- Equities
- 4534 Stock
- Company Mochida Pharmaceutical Co., Ltd.